![]() Chiropractic Clinic Of Three Forks Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 217 Main St, Three Forks, MT 59752 Phone: 406-285-6935 Fax: 406-285-6935 |
![]() Chiropractic Clinic Of Three Forks Chiropractor Medicare: Medicare Enrolled Practice Location: 113 Main St Ste A, Three Forks, MT 59752 Phone: 406-285-6935 Fax: 406-285-6874 |
![]() Dr. Jacob Edward Boll, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 25 Jefferson River Rd, Three Forks, MT 59752 Phone: 712-260-0831 |
![]() Jack Howard Berg, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 113 Main St Ste A, Three Forks, MT 59752 Phone: 406-285-6935 Fax: 406-285-6874 |
News Archive
With the obesity rate rising for American adults and children, health concerns such as diabetes and cardiovascular disease are a frequent reality. Although obesity itself is a major risk factor for disease, most of the threat may be associated with a cluster of risk factors called the metabolic syndrome (MetS). Losing weight can improve health and reduce these risk factors, but many people have difficulty keeping the weight off.
Parents of children and adolescents with autism spectrum disorders sometimes report that their children suffer from gastrointestinal symptoms, such as diarrhea and constipation. However, studies on how prevalent these symptoms are have had conflicting results.
Dragon Pharmaceutical Inc. announced that based on the receipt of preliminary proxies, the Company believes that it has sufficient votes to approve the Agreement and Plan of Merger by and among Dragon, Chief Respect Limited, Datong Investment Inc., a subsidiary of Chief Respect Limited, and Mr. Yanlin Han.
Chagas disease - the third most common parasitic infection in the world - affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.
The study titled Event Pulse Preview: Multiple Sclerosis shows that 84% of neurologists expect to prescribe Gilenia for some MS patients if approved, but prescribing will likely be limited to second- or third-line therapy until concerns about safety and monitoring requirements are resolved.
› Verified 7 days ago